Article Information
Accepted for Publication: April 3, 2019.
Published: May 31, 2019. doi:10.1001/jamanetworkopen.2019.4980
Open Access: This is an open access article distributed under the terms of the
CC-BY License. © 2019 Lam AP et al.
JAMA Network Open.
Corresponding Author: Alexandra Philipsen, MD, Department of Psychiatry and Psychotherapy, University of
Bonn, Siegmund-Freud-Straße 25, Bonn D-53127, Germany (
alexandra.philipsen@
123456ukbonn.de
).
Author Contributions: Drs Graf and Philipsen had full access to all of the data in the study and take responsibility
for the integrity of the data and the accuracy of the data analysis. Drs Lam and Matthies
contributed equally to this work.
Concept and design: Lam, Matthies, Graf, Retz, Jans, Berger, Tebartz van Elst, Philipsen.
Acquisition, analysis, or interpretation of data: Lam, Matthies, Graf, Colla, Jacob, Sobanski, Alm, Rösler, Retz-Junginger, Kis, Abdel-Hamid,
Müller, Lücke, Huss, Jans, Tebartz van Elst, Philipsen.
Drafting of the manuscript: Lam, Matthies, Graf, Rösler, Müller, Philipsen.
Critical revision of the manuscript for important intellectual content: Lam, Matthies, Graf, Colla, Jacob, Sobanski, Alm, Retz, Retz-Junginger, Kis, Abdel-Hamid,
Müller, Lücke, Huss, Jans, Berger, Tebartz van Elst, Philipsen.
Statistical analysis: Lam, Graf, Philipsen.
Obtained funding: Retz, Jans, Tebartz van Elst, Philipsen.
Administrative, technical, or material support: Matthies, Colla, Rösler, Retz, Retz-Junginger, Abdel-Hamid, Muller, Huss, Jans, Berger,
Tebartz van Elst, Philipsen.
Supervision: Matthies, Colla, Sobanski, Retz, Kis, Müller, Huss, Berger, Tebartz van Elst, Philipsen.
Conflict of Interest Disclosures: Dr Lam reported receiving speaker’s honoraria and travel grants from Medice Arzneimittel
Pütter GmbH and having authored books and articles on ADHD published by Elsevier,
Thieme Medical Publishers, Springer, and Oxford University Press. Dr Matthies reported
receiving speakers’ fee from Janssen-Cilag and being involved in clinical trials conducted
by Janssen and Lundbeck outside the submitted work. Dr Colla reported serving on the
advisory boards of Eli Lilly and Co, Janssen, and Novartis; receiving speaker honoraria
from Eli Lilly and Co and Novartis; and participating in phase 3 studies with Eli
Lilly and Co and Novartis outside the submitted work. Dr Jacob reported serving on
the advisory board of Medice, Janssen, and Shire and receiving honoraria from Shire
and Janssen. Dr Sobanski reported receiving honoraria from Medice, Eli Lilly and Co,
and Novartis; serving as a member of the advisory boards of Medice, Shire, Eli Lilly
and Co; and participating in trials with Medice, Novartis, Janssen-Cilag, and Eli
Lilly and Co. Dr Alm reported receiving honoraria from Medice; serving on the advisory
board of Eli Lilly and Co; participating in phase 3 studies with Medice, Novartis,
Janssen-Cilag, and Eli Lilly and Co; and participating in investigator-initiated trials
with Eli Lilly and Co. Dr Rösler reported serving as a member of the advisory boards
of Medice, Eli Lilly and Co, and Janssen; serving as a member of the speakers’ bureaus
of Medice, Eli Lilly and Co, Shire, and Novartis; and performing clinical studies
for Medice. Dr Retz reported receiving honoraria from Medice; serving as a member
of the advisory board of Medice; and participating in clinical trials sponsored by
the Federal Ministry of Education and Research, Novartis, and Medice. Dr Kis reported
receiving honoraria from Medice, Servier Laboratories, and Eli Lilly and Co; serving
as a member of the advisory boards of Medice, Servier Laboratories, and Shire; receiving
personal fees and nonfinancial support from Medice, Eli Lilly and Co, and Han-Huber
publishers; and being the author and editor of book chapters on ADHD psychopathology
and diagnostic instruments published by the Hogrefe publishing group. Dr Abdel-Hamid
reported being the author and editor of diagnostic instruments published by the Hogrefe
publishing group. Dr Müller reported receiving honoraria and travel grants from Servier
Laboratories and LivaNova. Dr Huss reported serving as a member of the advisory boards
of Eli Lilly and Co, Engelhardt Arzneimittel, Janssen-Cilag, Medice, Novartis, Shire,
and Steiner Arzneimittel within the past 5 years; serving as a consultant to Engelhardt
Arzneimittel, Medice, and Steiner Arzneimittel; receiving honoraria from Eli Lilly
and Co, Engelhardt Arzneimittel, Janssen-Cilag, Medice, Novartis, and Shire; and receiving
unrestricted grants for investigator-initiated trials from Eli Lilly and Co, Medice,
Engelhardt Arzneimittel, and Steiner Arzneimittel. Dr Jans reported authoring books
and articles on psychotherapy. Dr Tebartz van Elst reported serving on advisory boards,
delivering lectures, and receiving travel grants within the last 3 years from Eli
Lilly and Co, Janssen-Cilag, Novartis, Shire, UCB, GlaxoSmithKline, Servier Laboratories,
Janssen, and Cyberonics. Dr Philipsen reported serving on the advisory board for Shire;
receiving honoraria from Takeda; receiving travel support from Janssen-Cilag; and
delivering lectures, participating in phase 3 studies, and receiving travel grants
from Eli Lilly and Co, Janssen-Cilag, Medice, Novartis, and Shire; and being the author
of books and articles on psychotherapy published by Elsevier, Hogrefe, Schattauer,
Kohlhammer, and Karger publishers. No other disclosures were reported.
Funding/Support: The study was part of a multicenter research network on the psychotherapy of ADHD
funded by the German
Federal Ministry of Education and Research (BMBF; 01GV0605, 01GV0606, ADHD-NET).
Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management,
analysis, and interpretation of the data; preparation, review, or approval of the
manuscript; and decision to submit the manuscript for publication.
Group Information: The Comparison of Methylphenidate and Psychotherapy in Adult ADHD Study (COMPAS)
Consortium includes the following members: Isabella Heuser, MD (director), Michael
Colla, MD, Laura Gentschow, DiplPsych, Paula Kunze, DiplPsych, and Daina Langner,
PhD, Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Charité–University
Medicine Berlin, Berlin, Germany; Alexandra Lam, MD, Department of Psychiatry and
Psychotherapy, University of Bonn, Bonn, Germany; Jens Wiltfang, MD (director), Bernhard
Kis, MD, Mona Abdel-Hamid, PhD, Viola Heinrich, Dr rer medic, Markus Krämer, MD, and
Jennifer Uekermann, PhD, Department of Psychiatry and Psychotherapy, LVR-Hospital
Essen, Faculty of Medicine, University of Duisburg-Essen, Duisburg and Essen, Germany;
Alexandra Philipsen, MD (coordinating investigator), Erika Graf, PhD, Swantje Matthies,
MD, Marc Loewer, MD, Patricia Borel, DiplPsych, Imke Jansen, MD, Steffi Bonfico, DiplPsych,
Manuel Jooßens, DiplPsych, Chiharu Sadohara, DiplPsych, Manfred Weber, Melanie Kamp,
Tatja Dopatka, DiplBiol, Evgeniy Perlov, MD, and Harald Richter, PhD, Department of
Psychiatry and Psychotherapy, University Medical Center Freiburg, University of Freiburg,
Freiburg, Germany; Michael Rösler, MD, Wolfgang Retz, MD, Petra Retz-Junginger, PhD,
Konstanze Roemer, MD,Birgit Leipnitz, MD, Sabine Doyran, MD, and Monika Schulte-Altedorneburg,
MD, Institute for Forensic Psychology and Psychiatry, Saarland University Medical
Center and Saarland University Faculty of Medicine, Homburg/Saar, Germany; Christine
Carl, PhD, and Clemens Keutler, MD (director), Department of Child and Adolescent
Psychiatry and Psychotherapy, St Elisabethen Krankenhaus, Lörrach, Germany; Michael
Huss, MD, Catherine Kornmann, DiplPsych, Arne Bürger, PhD, Galina Chervenkova, MD,
and Patricia Meinhardt, Department of Child and Adolescent Psychiatry and Psychotherapy,
University Medicine Mainz, Mainz, Germany; Andreas Meyer-Lindenberg, MD (director),
Esther Sobanski, MD, Barbara Alm, MD, Martina Schumacher-Stien, DiplPsych, Simon Bukow,
MD, and Sotiria Argiriou-Martin, Department of Psychiatry and Psychotherapy, Central
Institute of Mental Health, Clinical Faculty Mannheim, University of Heidelberg, Mannheim,
Germany; Jürgen Deckert, MD (director), Andreas Warnke, MD (director), Christian Jacob,
MD, Thomas Jans, PhD, Silke Groß-Lesch, MD, Monika Heine, MD, Andrea Boreatti-Hümmer,
MD, Julia Heupel, Susanne Reichert, MD, Sabine Müller, Susanne Kreiker, MD, Alexandra
Gessner, Annette Conzelmann, DiplPsych, and Christina Bähne, DiplPsych, Department
of Psychiatry, Psychosomatics and Psychotherapy and Department of Child and Adolescent
Psychiatry, Psychosomatics, and Psychotherapy, University Hospital of Würzburg, Würzburg,
Germany; and Rainer Bredenkamp, MD (director), Gabriele Ihorst, PhD, and Erika Graf,
PhD, Clinical Trials Unit, University Medical Center, University of Freiburg, Freiburg,
Germany. The independent data monitoring committee included Helmut Remschmidt, MD,
Department of Child and Adolescent Psychiatry, Philipps University, Marburg, Germany;
Gernot Wassmer, PhD, Institute for Medical Statistics, Informatics, and Epidemiology,
University of Cologne, Cologne, Germany; and Norbert Wodarz, MD, Department of Psychiatry,
University of Regensburg, Regensburg, Germany. Independent supervision was carried
out by Ulrike Frank, PhD, Institute for Psychology of Freiburg University, with Friederike
Mayer-Bruns, MD, and Kirsten Schehr, PhD, private practice, Freiburg, Germany; health
economic evaluation was planned and conducted by Michael Schlander, MD, Institute
for Innovation and Valuation in Health Care, Wiesbaden, Germany.
Additional Information: Other projects in our network on psychotherapy research in ADHD (speaker: Alexandra
Philipsen, MD; 2006-2012, Andreas Warnke, MD, University Hospital of Würzburg, Würzburg,
Germany) are coordinated by Thomas Jans, PhD (ADHD in mothers and children), Ludger
Tebartz van Elst, MD (functional and morphometric brain mapping), and Klaus-Peter
Lesch, MD, University Hospital of Würzburg (molecular genetics).
Additional Contributions: MEDICE Arzneimittel Puetter GmbH and Co KG provided the trial medication (Medikinet
retard licensed as Medikinet adult and matching placebo). Roland Fischer, MD (MEDICE
Arzneimittel Pütter GmbH and Co KG), gave his advice in preparing the study protocol,
and he assisted in the serious adverse events management. He was not compensated for
his work.